Last update 08 May 2025

GI-264879A

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
NPY1R
Action
antagonists
Mechanism
NPY1R antagonists(neuropeptide Y receptor Y1 antagonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Obesity
Originator Organization
GlaxoSmithKline, Inc.
Active Organization-
Inactive Organization
Glaxo Wellcome, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC41H44F3N5O5
InChIKeyNZGALICACGXBQM-HOBHVFGFSA-N
CAS Registry338776-71-9

Related

100 Clinical Results associated with GI-264879A
Login to view more data
100 Translational Medicine associated with GI-264879A
Login to view more data
100 Patents (Medical) associated with GI-264879A
Login to view more data
1
Literatures (Medical) associated with GI-264879A
01 Mar 2001PeptidesQ3 · MEDICINE
Food intake inhibition and reduction in body weight gain in rats treated with GI264879A, a non-selective NPY-Y1 receptor antagonist
Q3 · MEDICINE
100 Deals associated with GI-264879A
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPreclinical
United States
Glaxo Wellcome, Inc.
02 Mar 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free